Gut Microbiome and Intestinal Permeability Are Promising Targets for Treating Nonalcoholic Fatty Liver Disease

Background: Nonalcoholic fatty liver disease (NAFLD) is a leading liver disease worldwide with a prevalence of approximately 24% among adult population. It is a spectrum of liver disorders ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). Obesity, insulin resistance, inflammation...

Descripción completa

Detalles Bibliográficos
Autor principal: Heshmati, Hassan Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265987/
http://dx.doi.org/10.1210/jendso/bvab048.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265987/
http://dx.doi.org/10.1210/jendso/bvab048.024

Ejemplares similares